Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read about a new 'Trojan Horse' cancer treatment, our new cancer drug access report or our childhood leukaemia appeal.

New organ sparing radiotherapy plan could reduce treatment side effects

A new way to plan radiotherapy could help shape treatment away from sensitive organs near tumours to reduce side-effects, a new study shows.
Read more
Curing brain cancer – the challenges ahead

Researchers and clinicians from across the world, have come together to set out how future research can finally deliver major progress against brain cancer in both adults and children.
Read more
ICR photography competition showcases stunning images of tumour cells in action

Every year our researchers submit outstanding pictures to our Science and Medical Imaging Competition – telling a story about our pioneering work and its benefits for patients.
Read more
ICR hails £350m tender as ‘major milestone’ for London Cancer Hub

The ICR has welcomed the launch of a £350 million tender to find a commercial development partner for The London Cancer Hub as a major milestone in turning the vision for the project into reality.
Read more
Help us make childhood leukaemia a thing of the past

Over the past 40 years, Professor Mel Greaves has been carrying out research to increase our understanding of childhood leukaemia, particularly how the most common form of this disease, acute lymphoblastic leukaemia (ALL), develops.
Support us

1/5

Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more